Navigation Links
Sigma-Aldrich(R) Becomes First Life Science Company to Publish in Peer-Reviewed Video Journal JoVE
Date:9/17/2008

ST. LOUIS, Sept. 17 /PRNewswire-FirstCall/ -- Sigma-Aldrich (Nasdaq: SIAL) today announced the publication of its first peer-reviewed video protocol in the PubMed accessible Journal of Visualized Experiments (JoVE). This makes Sigma-Aldrich the first life science company to submit a video protocol to the traditional scientific publication process. Peer-reviewed video protocols are an innovative and highly effective tool to increase the efficiency of scientific communication and with it the speed of basic research and drug discovery (http://www.jove.com/index/Details.stp?ID=899).

"Producing peer reviewed resources and making them available in locations that researchers trust is an invaluable tool for the research community," said John Custer, Marketing Manager-Biochemistry for Sigma-Aldrich. "We look forward to hearing our customers' feedback while we continue working on additional video protocols."

Less than two years old, JoVE is a scientific journal that publishes video articles of biological experiments from leading academic institutions including Harvard, MIT, Stanford, and Berkeley. JoVE recently became the first and only video-based scientific journal to be indexed in MEDLINE and PubMed, the official repositories of the National Library of Medicine (NLM) at the National Institute of Health (NIH).

"Scientists depend on fast access to high quality information both from other scientists and increasingly from industry. The fact that an industry leader dedicates its resources to make its scientific knowledge accessible using the most innovative forms of scientific communication will strongly benefit the scientific community," said Klaus Korak, co-founder of JoVE.

The first video protocol titled, Sigma's Non-Specific Protease Activity Assay -- Casein as a Substrate, is a multipurpose protease assay employed by life science researchers in academia, biotech, and pharmaceutical industry. The video protocol can be viewed on JoVE and the Sigma Aldrich website and is available in both English and Chinese. Sigma Aldrich plans to continue creating video protocols spanning many different topics of scientific research.

About Sigma-Aldrich: Sigma-Aldrich is a leading Life Science and High Technology company. Our biochemical and organic chemical products and kits are used in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical and other high technology manufacturing. We have customers in life science companies, university and government institutions, hospitals, and in industry. Over one million scientists and technologists use our products. Sigma-Aldrich operates in 36 countries and has 8,000 employees providing excellent service worldwide. Sigma-Aldrich is committed to Accelerating Customer Success through Leadership in Life Science, High Technology and Service. For more information about Sigma-Aldrich, please visit our award-winning website at http://www.sigma-aldrich.com.

About JoVE: JoVE is the first-and-only video-based scientific journal indexed in MEDLINE and PubMed. JoVE was founded in October 2006 as the first online journal devoted to video-publication of life science research. This novel, dynamic, and visual approach to scientific publishing aims to increase the reproducibility of published studies and to improve the efficiency of research in the biological sciences. JoVE has assembled an Editorial Board that includes 24 scientists from Harvard, Princeton, NIH, and other leading institutions across the US, Europe, and Japan. JoVE has so far released 19 monthly issues including over 230 video protocols on experimental approaches in developmental biology, neuroscience, microbiology and other fields. To facilitate the integration of video content into scientific publishing, JoVE has developed an organizational and technical infrastructure to perform and/or assist scientists with filming and editing in their labs. For more information please contact: klaus.korak@jove.com.


'/>"/>
SOURCE Sigma-Aldrich
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Sigma-Aldrich(R) Becomes First Life Science Company to Publish in PubMeds Peer-Reviewed Video Journal JoVE
2. MD Anderson Becomes a GeneGo Center of Excellence Using MetaCore for Oncology Research
3. Truman Medical Centers Becomes One of the First Hospitals in the U.S. To Install the Worlds First Adaptive 128-slice CT Scanner
4. University of Miami Miller School of Medicine Becomes a GeneGo Center of Excellence
5. 18-Month Extension of Reimbursement Rates for Radioimmunotherapies Becomes Law After Congressional Override of Presidential Veto
6. Yale Keck Microarray Center Becomes a GeneGo Center of Excellence
7. Medical Ventures Becomes Neovasc with Two Corporate Acquisitions and $8.3 Million Financing
8. SURGEX(TM) Becomes the Official Sports Nutrition Drink of Former NBA Player Dee Brown and his Edge Basketball Training Facility
9. Bioheart Founder, Howard J. Leonhardt, Becomes Chairman of the Board of Directors
10. REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide
11. Prof. Michel Klein Becomes Chief Scientific Officer at AMVAC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... , Feb. 23, 2017  Seattle,s upscale Capitol Hill ... a strange place for a head lice treatment salon to ... between a Tuscan restaurant and a French bistro on E ... perfect. "We aren,t just any old lice clinic, we pride ... feel comfortable, and release some of the stigma associated with ...
(Date:2/23/2017)... ... 2017 , ... Today, researchers can fast-track sample collection and ... other biomarkers or SNPs of interest) using one, easy-to-collect saliva sample. With the ... between insulin and other relevant biomarkers can be extensively studied through a non-invasive ...
(Date:2/23/2017)... USA, and CARDIFF, UK (PRWEB) , ... February ... ... international society for optics and photonics , have been named Fellows of the ... significant scientific and technical contributions in the multidisciplinary fields of optics, photonics, and ...
(Date:2/22/2017)... CINCINNATI , Feb. 22, 2017 Scientists ... drives inflammation and organ damage in Gaucher and maybe ... fewer risks and lower costs than current therapies. ... Children,s Hospital Medical Center , which also included investigators ... , report their data Feb. 22. The study ...
Breaking Biology Technology:
(Date:2/10/2017)... 2017 Research and Markets has ... Medicine - Scientific and Commercial Aspects" to their offering. ... ... integrated with therapy for selection of treatment as well for ... prevention of disease in modern medicine. Biochip/microarray technologies and next ...
(Date:2/8/2017)... YORK , Feb. 7, 2017 Report Highlights ... The ... should reach $11.4 billion by 2021, growing at a compound ... Includes - An overview of the global markets for synthetic ... 2015, estimates for 2016, and projections of compound annual growth ...
(Date:2/7/2017)... Ind. , Feb. 7, 2017 Zimmer ... leader in musculoskeletal healthcare, will present at the LEERINK ... New York Palace Hotel on Wednesday, February 15, 2017 ... live webcast of the presentation can be accessed at ... replay following the conference via Zimmer Biomet,s Investor Relations ...
Breaking Biology News(10 mins):